QuickGly™ is the world’s first non-invasive device that measures glycated hemoglobin (HbA1c) in real-time, essential for diabetes management. Unlike devices that measure blood sugar, it measures HbA1c, reflecting the average blood sugar level over the past three months.

We hold related patents (9 Korean registered, 4 US pending). The product allows cost-effective diabetes diagnosis and HbA1c monitoring anytime, anywhere. It connects to iOS and Android devices via Bluetooth for easy data tracking.

This patented product enhances health security by enabling remote diabetes diagnosis and promoting health in underdeveloped countries through free patent licensing, improving global health accessibility and equity.